Teva enlarges workforce for first time since 2016
The Israeli pharmaceutical company had 36,472 employees at the end of 2023, up 3.8% from 2022, as Teva returns to growth.
Source: globes.co.il
📰 Kare Schulz News
Kare Schulz News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Kare Schulz. Real-time updates on events, politics, business and more.
Teva once again most valuable company on TASE
The Israeli pharmaceutical company's share price has risen 50% over the past six months but is still 80% down on its peak in 2015.
Source: globes.co.il
Teva Pharmaceutical Stock: Stuck In A Cycle Of Hope And Disappointment
Teva Pharmaceuticals undoing was its $40.5B deal to acquire Allergans generic drug business in 2015. Read why TEVAs 56% run in the stock price makes it a Sell.
United States Kare Schulz Teva Pharmaceutical Industries Stock Editorial Pharmaceutical Industries Seeking Alpha
Source: seekingalpha.com